Home › Funds › Empyrean Capital Partners, LP › TNDM

Empyrean Capital Partners, LP position in TNDM

TANDEM DIABETES CARE INC · Health Care

Empyrean Capital Partners, LP reported holding 19,282,000 shares of TNDM (TANDEM DIABETES CARE INC) in its Q3 2026 13F filing — a position valued at US$18.4M, representing 0.78% of its reported portfolio and ranking #42 among its reported holdings. Empyrean Capital Partners, LP has disclosed TNDM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)19.28M sh
Reported value held$18.45M
Portfolio Weight0.78%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Empyrean Capital Partners, LP's TNDM position evolved

Empyrean Capital Partners, LP first disclosed a stake in TNDM in Q2 2026 at 18,500,000 shares (US$17.7M). The position peaked in Q3 2026 at 19,282,000 shares, worth US$18.4M. Across 2 filings, Empyrean Capital Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,282,000 shares valued at US$18.4M — an increase of 782,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 18.50M $17.67M New
Q3 2026 19.28M $18.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNDM and 13F data

TNDM (TANDEM DIABETES CARE INC) is a Health Care company. 18 other funds we track also report a position in TNDM — the largest reported positions include First Light Asset Management, LLC (US$53.0M), Longaeva Partners L.P. (US$38.5M), Paradice Investment Management LLC (US$32.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNDM

All TNDM fund holders →

FAQ

How long has Empyrean Capital Partners, LP held TNDM?

Empyrean Capital Partners, LP has disclosed TNDM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Empyrean Capital Partners, LP's current position in TNDM?

As of Q3 2026, Empyrean Capital Partners, LP holds 19.28M shares of TNDM (TANDEM DIABETES CARE INC), valued at $18.45M, representing 0.78% of its reported portfolio and ranking #42.

Has Empyrean Capital Partners, LP been buying or selling TNDM?

In the latest 13F filing (Q3 2026), Empyrean Capital Partners, LP increased its position in TNDM. The position peaked in Q3 2026 at 19.28M shares.

Which other funds hold TNDM?

Other major institutional holders of TNDM include First Light Asset Management, LLC, Longaeva Partners L.P., Paradice Investment Management LLC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.